DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$8.89
-0.08 (-0.89%)
▼
5d:
-2.31%
30d:
-0.11%
90d:
-13.69%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation
DCTH is down 7.2% this week, but smart money is accumulating calls. Top strike: $12.5 2026-05-15 with 1,090 OI. Call ratio: 68% View Scanner →
Strength: 5.4/10
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 0% growth. Moderate conviction.
💡 BUY OPPORTUNITY: DCTH shows positive signals but monitor for confirmation. Market pricing in 0% growth. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $8.89, which is considered oversold relative to its 30-day fair value range of $8.94 to $9.69. From a valuation perspective, the stock is trading at a discount (Forward PE: -45.4) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is showing sideways momentum. The price is currently testing key support at $8.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DCTH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.33 (+140.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DCTH is showing sideways momentum. The price is currently testing key support at $8.85. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DCTH has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $21.33 (+140.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$8.94 -
$9.69
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
65.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 140.0% below Wall St target ($21.33)
Fair Price Analysis
30-Day Fair Range
$8.94 -
$9.69
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.84
(9.4%)
Support & Resistance Levels
Support Level
$8.85
Resistance Level
$9.98
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-45.36
Wall Street Target
$21.33
(+140.0%)
Revenue Growth (YoY)
37.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
3.2%
PE vs Historical
-45.4 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: March 30, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Gerard J Michel
BUY
11500 shares
2025-11-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 56 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 61 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 50 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 59 HOLD |
